These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4464960)

  • 21. Cardiac output in patients with disturbed cardiac rhythm.
    Lukomsky PE
    Cor Vasa; 1970; 12(2):97-105. PubMed ID: 5433135
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adenosine in the treatment of supraventricular arrhythmias].
    Lommi J; Pohjola-Sintonen S
    Duodecim; 1994; 110(5):473-7. PubMed ID: 7555840
    [No Abstract]   [Full Text] [Related]  

  • 23. [The differentiated treatment of paroxysmal supraventricular disorders of heart rhythm in patients with ischemic heart disease at the prehospital stage depending on the hemodynamic state at the moment of the arrhythmia].
    Olesin AI; Lovkacheva MK
    Ter Arkh; 1988; 60(12):98-104. PubMed ID: 3247665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of a new anti-arrhythmia preparation ethacizin (a diethylamine analog of ethmozin) on the heart conduction system in different forms of heart rhythm disorder].
    Smetnev AS; Shugushev KhKh; Rozenshtraukh LV; Shevchenko NM
    Ter Arkh; 1983; 55(1):92-5. PubMed ID: 6340241
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of arrhythmias].
    Rothlin M
    Schweiz Rundsch Med Prax; 1973 Feb; 62(8):210-4. PubMed ID: 4690784
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experience with the treatment of supraventricular hyperkinetic arrhythmias by high-frequency atrial electrostimulation].
    Menozzi C; Lolli G; Monducci I; Guiducci U; Gheller G; Brignole M; Bertulla A
    Minerva Cardioangiol; 1982 Sep; 30(9):483-8. PubMed ID: 7155383
    [No Abstract]   [Full Text] [Related]  

  • 27. [The therapy of supraventricular abnormal rhythms with Orciprenalin in the so-called transition phase after cardioversion].
    Olesch K; Belz GG
    Z Kreislaufforsch; 1970 Oct; 59(10):942-9. PubMed ID: 5489246
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antiarrhythmic effect of iproveratril].
    Fehér L; Kiss E; Vágfalvy I
    Z Gesamte Inn Med; 1971 Mar; 26(6):202-4. PubMed ID: 5562202
    [No Abstract]   [Full Text] [Related]  

  • 29. [Electrophysiologic effects of bepridil on the human heart].
    Valère PE; Belin A; Chentir T; Lehner JP; Guerot C; Tricot R
    Ann Cardiol Angeiol (Paris); 1982; 31(5):409-15. PubMed ID: 6984315
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anti-arrhythmic therapy in childhood].
    Singer H; Eschenbacher HL; Gutheil H
    Fortschr Med; 1975 Oct; 93(30):1447-9. PubMed ID: 1225801
    [No Abstract]   [Full Text] [Related]  

  • 31. [Arrhythmogenic effect of anti-arrhythmia drugs].
    Trusz-Gluza M
    Kardiol Pol; 1991; 34(1):41-8. PubMed ID: 2051713
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cardiac arrhythmia and its therapy].
    Mürtz R; Veltmann G; Jorde R; Begenat H
    Med Monatsschr; 1970 Jun; 24(6):239-45. PubMed ID: 5525110
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cardiac rhythm and conduction disturbances during surgical correction of the patent atrioventricular canal].
    Taraian MV; Cherepenin LP; Nechaenko MA; Ivanov AS; Minaev VV; Iakovchuk AM
    Vestn Ross Akad Med Nauk; 1998; (6):32-5. PubMed ID: 9771112
    [No Abstract]   [Full Text] [Related]  

  • 34. Non-classical indications for cardiac resynchronization therapy.
    Beinart R; Michaelidis A; Glikson M
    Hellenic J Cardiol; 2009; 50(3):208-15. PubMed ID: 19465362
    [No Abstract]   [Full Text] [Related]  

  • 35. [Our observations on the treatment of arrhythmia in the postoperative period after direct revascularization of the myocardium].
    Iwaszkiewicz A; Moll J; Rychter J; Tomaszewska L; Golec E; Jaszewski R; Kesiak J; Zasłonka J; Zwoliński M
    Pol Tyg Lek; 1983 Apr; 38(15):453-6. PubMed ID: 6605527
    [No Abstract]   [Full Text] [Related]  

  • 36. Do we need new antiarrhythmic compounds in the era of implantable cardiac devices and percutaneous ablation?
    Christ T; Ravens U
    Cardiovasc Res; 2005 Dec; 68(3):341-3. PubMed ID: 16256089
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current state and perspectives of the study of cardiac rhythm disorders].
    Mazur NA
    Kardiologiia; 1978 Apr; 18(4):5-11. PubMed ID: 671966
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacologic therapy of cardiac arrhytmias].
    Visco G
    Policlinico Prat; 1971 Jan; 78(1):1-22. PubMed ID: 5547888
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of arrhythmia].
    Mashiba H
    Nihon Naika Gakkai Zasshi; 1983 Jun; 72(6):737-41. PubMed ID: 6655328
    [No Abstract]   [Full Text] [Related]  

  • 40. [The use of propafenon in the acute and chronic treatment of supraventricular and ventricular arrhythmias].
    Menozzi C; Lolli G; Gheller G; Monducci I; Vergoni W; Cattabiani ML; Manenti E; Casali G
    Clin Ter; 1983 Apr; 105(2):125-33. PubMed ID: 6345053
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.